Samin K. Sharma
- DEAN OF INTERNATIONAL CLINICAL AFFILIATIONS
- PROFESSOR Medicine, Cardiology
American Board of Internal Medicine
MD, Medical College Jaipur
Residency, Internal Medicine
New York University Downtown Hosp.
City Hospital Center at Elmhurst
Dr. Samin K. Sharma performs over 1500 complex coronary interventions annually (the highest in the country) while achieving an extremely low complication rate. According to New York State Department of Health reports, he has the highest angioplasty success rate (lowest mortality less than 0.1 percent) for an interventional cardiologist in the state since 1994. Under Dr. Sharma's leadership, Mount Sinai Heart has become one of the best and busiest centers in New York, providing excellent care for all types of simple and complex high-risk heart patients. In addition to coronary interventions, Dr. Sharma specializes in the non-surgical treatment of mitral and aortic stenosis (balloon valvuloplasty). Dr. Sharma is the Zena and Michael A. Wiener Professor of Medicine at the Icahn School of Medicine at Mount Sinai.
Dr. Sharma serves on the Cardiac Advisory Board of the New York State for coronary interventions that advises the health department and the Governor on issues of health policies and supervision, safety and appropriateness of the heart care by various hospitals in New York. Recently Dr. Sharma received the Governor's Award of Excellence (2006) for his outstanding contributions to medicine.
Dr. Sharma also has passion for teaching and fellows enjoy learning from his expertise, so much so they awarded him the Simon Dack Best Teacher in Cardiology in 2000. Dr. Sharma travels to India four-to-six times a year to teach the art of angioplasty to Indian cardiologists. In addition to various academic awards, Dr. Sharma also received numerous awards from non-academic society such as the "Rajasthan Gaurav" given by the Sanskriti organization of Rajasthan and the Rajive Gandhi Memorial Award.
Under the directorship of Dr. Sharma, the Live Symposium of Complex Coronary Cases started in 1998 and has had overwhelming success every year (attended by more than 400 delegates). Major emphasis of the live course has been the technical aspects of safely performing complex coronary interventions involving rotational atherectomy, thrombectomy, and stenting.
Dr. Sharma is widely published on topics of rotational atherectomy, newer interventional devices and drug eluting stents, as well as how to reduce various complications of coronary intervention by the use of beta-blockers and GP IIb/IIIa inhibitors and appropriate techniques for the interventional devices. He is especially interested in discovering ways to treat and reduce in-stent restenosis.
A regular fixture on international, national, local TV stations, newspapers, and magazines; Dr. Sharma has been the focus of news stories for outlets like The Today Show, The New York Times, The Wall Street Journal, New York Magazine, Barron's, Forbes, Newsweek, The Washington Post, Crain's New York Business, Newsday, New York Post, New York Sun, Earthtimes, India Abroad, and India Today. He has received "Best Doctors" status by US News and World Report and has been included in the "Top Physicians" by Consumer Research Council of America and Castle Connelly magazines.
News Media Coverage:
Dr. Sharma talks about the symptoms of atherosclerosis and the minimally invasive procedures used to treat cardiac clogs in The Daily News feature "The Daily Check Up."
View the PDF.
Dr. Sharma discusses cardiac catheterization in The Daily News feature The Daily Check Up.
View the PDF
1. India Abroad on January 26, 2007 on AILF Immigrant Achievement Award.
2. New York Times, on Saturday, October 26, 2006: "Doctors Rethink the Widespread Use of Stents."
3.New York Magazine for "When Heart Surgeons Turn Patients Away," October 2005.
4.New York Magazine for Best Doctors in New York 2004-2007.
5. The Washington Post on September 16, 2003 article on "The selling of the stent" quotes Dr Sharma regarding the benefits and cost of the drug-coated stents.
6. Wall Street Journal on April 25 article on "New coated stents: FDA clears the use of new stents."
7. New York Post March 12 2003 issue reported Mount Sinai Hospital and Dr Sharma boasted the best mortality rate of angioplasty statewide.
8. India Today on March 3, 2003 article on "Heart alert: Asians under attack."
9. ITV cable news show on December 7, 2001 on newer angioplasty techniques.
10. CNN news reports on December 21, 1999 about coronary stenting versus balloon angioplasty during heart attack.
11. NBC evening news (channel 4) by Dr. Max Gomez on May 5, 1999 regarding the role of Angiojet in the treatment of arterial blockages.
12. Newsweek magazine March 8, 1999 article "Asians with bad hearts"
13. Forbes magazine December 28, 1998 article "Dr. Sharma's fasting day."
14. India Today December 14, 1998 featured article Magic Hands of Dr. Sharma.
15. CBS morning news on December 1, 1998 on use of rotablator in high-risk coronary interventions.
16. New York Newsday article on October 6, 1998 about personal profile and "taking the tough ones".
17. NBC evening news (channel 4) by Dr. Max Gomez on September 21, 1998 about rotablator for in-stent restenosis.
Jacobi Medallion Award
Mount Sinai Physician of the Year Award
Governor's Award of Excellence
Zena and Michael A. Wiener Professor of Medicine
Jaipur by Rajasthan Government of India
Simon Dack Award for Best Teacher at Cardiovascular Institute
The Mount Sinai Hospital
1996 - 2000
Center of Excellence Award for Rotational Coronary Atherectomy
1995 - 2003
Lowest complication rate of angioplasty
DOH New York State statistics
Best medical and chief resident
NY Infirmary-Beekman Downtown Hospital
Chen V, Sharma S. Coronary interventional devices: Balloon, atherectomy, thrombectomy and distal protection devices. Cardiol Clin 2006; 24(2): 201-215.
Wu C, Hannan E, Walford G, Ambrose J, Jones R, King S, Clark T, Katz S, Sharma S, Holmes D. A risk score to predict in-hospital mortality for percutaneous coronary interventions. J Am Coll Cardiol 2006; 47: 654-660.
Hannan E, Racz M, Holmes D, King S, Jones R, Ambrose J, Sharma S, Katz S, Clark L, Walford G. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation 2006; 113: 2406-2412.
Sharma S, Kini A, Mares A, Tamburino F. Improved outcome with AngioJet thrombectomy during primary stenting in acute myocardial infarction patients with high-grade thrombus. J Invasive Cardiol 2006; 18: 8C-11C.
Sharma S. Simultaneous kissing drug-eluting stent technique for percutaneous treatment of bifurcation lesions in large. Cathet Cardiovasc Interv 2005; 65: 10-16.
Agarwal A, Kini A, Attanti S, Sharma S, Ashtiani R, Steinheimer A, Moreno P, Lee P. Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years. Am J Cardiol 2005; 95: 43-47.
Lee P, Kini A, Sharma S, Fisher E, Ashan C. Anemia as a risk factor for Percutaneous Coronary Intervention. J Am Coll Cardiol 2004; 44: 541.
Erdel C, Sharma S, Marmur J, Kini A. The current status of rotational atherectomy. Cathet Cardiovasc Interv 2004; 62: 485.
Kim M, Sharma S, Kini A. Therapeutic options in patients with refractory angina. J Am Coll Cardiol 2002; 39: 923.
Kini A, Sharma S, Mitre C, Reich D. A risk stratification scheme for selection of a glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention based on clinical and angiographic criteria. Am J Cardiol 2001; 88: 1287.
- XIENCE V Everolimus Eluting Coronary Stent System (EECSS) USA Post-Approval Study
- JOSTENT Coronary Stent Graft
- COSTAR II Trial
- A Prospective, Single Blind, Randomized Controlled Study to Evaluate the Safety And Effectiveness of the Tryton Side Branch Stent™ used in Conjunction with a Drug-Eluting Stent Compared to Side Branch Balloon Angioplasty in Conjunction with a Drug-Eluting Stent in the Treatment of de novo Bifurcation Lesions Involving the Main Branch and Side Branch within the Native Coronary Circulation (TRYTON side-branch stent TRIAL)
- A Prospective, multi-center, randomized controlled trial of the IMPELLA RECOVER LP 2.5 System versus Intra Aortic Balloon Pump (IABP) in Patients Undergoing Non Emergent High Risk PCI [Protect II]
- A Prospective, Two-Arm, Open-Label, Multi-Center Registry using XIENCE PRIME EECSS and XIENCE PRIME LL EECSS (SPIRIT-PRIME)
- CObalt chromium STent with Antiproliferation for Restenosis II Trial
- Future Revascularization Evaluation in Patients with Diabetes Mellitus:Optimal Management of Multivessel Disease (FREEDOM Trial)
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Sharma during 2012 and/or 2013. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.
- Abbott Laboratories; AngioScore, Inc.; Boston Scientific Corporation; Daiichi-Sankyo Co., Ltd. / Eli Lilly and Company Partnership; The Medicines Company
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Eternal Heart Care Centre and Research Institute Private Limited (EHCRI)
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Klingenstein Clinical Center Floor 6th Floor Room 6N-665
1450 Madison Avenue
New York, NY 10029
1190 Fifth Avenue - 1 South
New York, NY 10029
- Wednesday 2:00pm - 6:30pm
- Indian (Hindi)
- Aetna U.S. Healthcare
- Beech Street
- Best Doctor
- CarePlus, LLC
- CenterCare, Inc.
- Devon Health Services
- Empire Blue Cross/Blue Shield
- Empire Health Choice, Inc.
- Fidelis Care NY
- First Health
- Group Health Insurance, Inc.
- Health Insurance Plan (HIP)
- HealthPlus, Inc.
- Horizon Healthcare
- Island Group
- Local 1199
- Medicaid New Jersey
- MetroPlus Health Plan
- MultiPlan, Inc.
- Neighborhood Health Providers, LLC
- Oxford Health Plans
- Private Healthcare Systems (PHCS)
- Travel Care Services
- United Health Care Empire Plan
- United Healthcare
- WellCare of New York, Inc.
- Master Card
- American Express
- Personal Check